Cargando…

HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport

HIV-1 must replicate in cells that are equipped to defend themselves from infection through intracellular innate immune systems. HIV-1 evades innate immune sensing through encapsidated DNA synthesis and encodes accessory genes that antagonize specific antiviral effectors. Here, we show that both par...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Hataf, Sumner, Rebecca P, Rasaiyaah, Jane, Tan, Choon Ping, Rodriguez-Plata, Maria Teresa, Van Tulleken, Chris, Fink, Douglas, Zuliani-Alvarez, Lorena, Thorne, Lucy, Stirling, David, Milne, Richard SB, Towers, Greg J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759385/
https://www.ncbi.nlm.nih.gov/pubmed/33300875
http://dx.doi.org/10.7554/eLife.60821
_version_ 1783627100830302208
author Khan, Hataf
Sumner, Rebecca P
Rasaiyaah, Jane
Tan, Choon Ping
Rodriguez-Plata, Maria Teresa
Van Tulleken, Chris
Fink, Douglas
Zuliani-Alvarez, Lorena
Thorne, Lucy
Stirling, David
Milne, Richard SB
Towers, Greg J
author_facet Khan, Hataf
Sumner, Rebecca P
Rasaiyaah, Jane
Tan, Choon Ping
Rodriguez-Plata, Maria Teresa
Van Tulleken, Chris
Fink, Douglas
Zuliani-Alvarez, Lorena
Thorne, Lucy
Stirling, David
Milne, Richard SB
Towers, Greg J
author_sort Khan, Hataf
collection PubMed
description HIV-1 must replicate in cells that are equipped to defend themselves from infection through intracellular innate immune systems. HIV-1 evades innate immune sensing through encapsidated DNA synthesis and encodes accessory genes that antagonize specific antiviral effectors. Here, we show that both particle associated, and expressed HIV-1 Vpr, antagonize the stimulatory effect of a variety of pathogen associated molecular patterns by inhibiting IRF3 and NF-κB nuclear transport. Phosphorylation of IRF3 at S396, but not S386, was also inhibited. We propose that, rather than promoting HIV-1 nuclear import, Vpr interacts with karyopherins to disturb their import of IRF3 and NF-κB to promote replication in macrophages. Concordantly, we demonstrate Vpr-dependent rescue of HIV-1 replication in human macrophages from inhibition by cGAMP, the product of activated cGAS. We propose a model that unifies Vpr manipulation of nuclear import and inhibition of innate immune activation to promote HIV-1 replication and transmission.
format Online
Article
Text
id pubmed-7759385
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-77593852020-12-28 HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport Khan, Hataf Sumner, Rebecca P Rasaiyaah, Jane Tan, Choon Ping Rodriguez-Plata, Maria Teresa Van Tulleken, Chris Fink, Douglas Zuliani-Alvarez, Lorena Thorne, Lucy Stirling, David Milne, Richard SB Towers, Greg J eLife Microbiology and Infectious Disease HIV-1 must replicate in cells that are equipped to defend themselves from infection through intracellular innate immune systems. HIV-1 evades innate immune sensing through encapsidated DNA synthesis and encodes accessory genes that antagonize specific antiviral effectors. Here, we show that both particle associated, and expressed HIV-1 Vpr, antagonize the stimulatory effect of a variety of pathogen associated molecular patterns by inhibiting IRF3 and NF-κB nuclear transport. Phosphorylation of IRF3 at S396, but not S386, was also inhibited. We propose that, rather than promoting HIV-1 nuclear import, Vpr interacts with karyopherins to disturb their import of IRF3 and NF-κB to promote replication in macrophages. Concordantly, we demonstrate Vpr-dependent rescue of HIV-1 replication in human macrophages from inhibition by cGAMP, the product of activated cGAS. We propose a model that unifies Vpr manipulation of nuclear import and inhibition of innate immune activation to promote HIV-1 replication and transmission. eLife Sciences Publications, Ltd 2020-12-10 /pmc/articles/PMC7759385/ /pubmed/33300875 http://dx.doi.org/10.7554/eLife.60821 Text en © 2020, Khan et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Microbiology and Infectious Disease
Khan, Hataf
Sumner, Rebecca P
Rasaiyaah, Jane
Tan, Choon Ping
Rodriguez-Plata, Maria Teresa
Van Tulleken, Chris
Fink, Douglas
Zuliani-Alvarez, Lorena
Thorne, Lucy
Stirling, David
Milne, Richard SB
Towers, Greg J
HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport
title HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport
title_full HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport
title_fullStr HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport
title_full_unstemmed HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport
title_short HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport
title_sort hiv-1 vpr antagonizes innate immune activation by targeting karyopherin-mediated nf-κb/irf3 nuclear transport
topic Microbiology and Infectious Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759385/
https://www.ncbi.nlm.nih.gov/pubmed/33300875
http://dx.doi.org/10.7554/eLife.60821
work_keys_str_mv AT khanhataf hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport
AT sumnerrebeccap hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport
AT rasaiyaahjane hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport
AT tanchoonping hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport
AT rodriguezplatamariateresa hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport
AT vantullekenchris hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport
AT finkdouglas hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport
AT zulianialvarezlorena hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport
AT thornelucy hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport
AT stirlingdavid hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport
AT milnerichardsb hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport
AT towersgregj hiv1vprantagonizesinnateimmuneactivationbytargetingkaryopherinmediatednfkbirf3nucleartransport